Bringing together leaders from biopharma, academia, and Dx developers to create a working group that dictates the direction and rhetoric of the evolving liquid biopsy story. Learn more.
With the continued evolution of transparency and reporting regulations, CBI’s 5th annual Investigator Initiated and Sponsored Research conference creates a platform to break out of the regulatory grey zone and create industry standards for FMV analysis, transparency and reporting practices.
DeviceTalks is back in California for DeviceTalks West on December 12, 2016. Join us at our 5-year anniversary celebration for an inside look at the state of medtech innovation in 2017, as we explore Google and Johnson & Johnson’s bid to change surgery with its spinout Verb Surgical. In addition, you’ll hear from leaders at Acelity, Halt Medical, Heartflow, Inc., Medtronic, Merit Medical, InTouch Healthcare and many more. Registration is open.
Checkpoint inhibitors were a start for immunotherapies in cancer—but it's clear that the best way to manipulate the immune system to better defend against cancer is to intervene in multiple ways in the immune response pathway. Join FierceBiotech editor Ben Adams and a panel of experts as they examine the relative strengths and weaknesses of various strategies in development. Register today.